AbbVie presses Shire shareholders for takeover

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

AbbVie (ABBV) CEO Richard Gonzalez has been holding discreet meetings with Shire (SHPG) shareholders in London this week, in another pursuit for a $46B takeover, Reuters reports.

AbbVie is looking to buy Shire mainly as a tax inversion, but to also diversify its drug portfolio.

The company made no mention of increasing its current bid, but under British takeover rules, it has until July 18 to make another offer or walk away.

SHPG -0.5% premarket